2024 -now Executive Director - Analytical Development, PRD @ Eli Lilly and Company
2021 -2023 VP, Head of Bioanalytical Biomarker and CMC Analytical Development @ Sigilon Therapeutics, a wholly owned subsidiary of Eli Lilly and Company
2013 -2021 Director, Translational Sciences @
2003 -2013 Associate Research Fellow (Pfizer); Principal Scientist III and Lab Head (Wyeth) @
2001 -2003 Group Leader, Sr Scientist @
1997 -2001 Sr Scientist @
Jiang Wu Education
Michigan State University
Ph.D. (Analytical Biochemistry)
Jiang Wu Summary
Jiang Wu, based in Cambridge, MA, US, is currently a Executive Director - Analytical Development, PRD at Eli Lilly and Company. Jiang Wu brings experience from previous roles at Sigilon Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, Takeda and Pfizer. Jiang Wu holds a Ph.D. in Analytical Biochemistry @ Michigan State University. Jiang Wu has 1 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.